Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell ...

Read here for an update on new investment opportunities in preferred stock and exchange traded debt offerings with yields ...

Precigen (PGEN) announced that it has entered into a securities purchase agreement for the sale of its 8.00% Series A Convertible Perpetual ...

Highlights,Convertible preferred stock allows holders to convert shares into common stock.,It combines the benefits of ...

In addition to this significant investment, Hyperscale Data is strategically spinning out all of its non-data center and non-Bitcoin mining assets. This move is aimed at refining the Company’s core ...

PG&E’s new 6% preferred stock offers a potential 25% upside. See why PCG stock could rise with successful wildfire prevention ...

In trading on Thursday, shares of Bank of America Corp's 7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L (Symbol: BAC.PRL) were yielding above the 6% mark based on its ...

of the company and $1.2B of newly issued Series A mandatory convertible preferred stock of the company. PG&E expects to grant to the underwriters of the offerings a 30-day option to purchase up to ...

OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology c ...

PG&E Corporation (NYSE:PCG) announced the successful completion of an underwriting agreement regarding its issuance of 28,000,000 shares of 6.000% Series A Mandatory Convertible Preferred Stock, with ...

Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement. The stock was up 17.5% at $4.44 in early trading. Shares ...